Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Solvay Pharmaceuticals Inc.

Division of Abbott Laboratories Inc./Solvay Pharmaceuticals SA

Latest From Solvay Pharmaceuticals Inc.

FTC Faces Uphill Battle In AndroGel Pay-For-Delay Suit

While the Federal Trade Commission won a court order requiring AbbVie to turn over documents in its AndroGel patent settlement the judge dismissed a big chunk of the agency’s complaint.

BioPharmaceutical Legal Issues

Don't Try This At Home: Zazzle-Created EstroGel Promo Card Fizzles With FDA

Low-grade sales piece touting cost savings with Ascend Therapeutics’ product lacks risk information; it is just the seventh Rx citation by FDA this year.

BioPharmaceutical United States

Pay-For-Delay Antitrust Suits May Settle More Often After Jury Verdict For AstraZeneca

Jury finds AstraZeneca’s Nexium patent infringement settlement with Ranbaxy was not antitrust violation; direct purchasers and third party payers claimed agreement was worth nearly $1 billion.

BioPharmaceutical United States

FTC vs. AbbVie Pay-For-Delay Suit Crafted For Supreme Court’s ‘Red Flag’ Test

But for the first time ever, Federal Trade Commissioners were split on whether to bring such a case; newer members voted ‘no.’

BioPharmaceutical United States
See All

Company Information